188 related articles for article (PubMed ID: 30623717)
1. Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of
Boiko AS; Ivanova SA; Pozhidaev IV; Freidin MB; Osmanova DZ; Fedorenko OY; Semke AV; Bokhan NA; Wilffert B; Loonen AJM
World J Biol Psychiatry; 2020 Jan; 21(1):72-77. PubMed ID: 30623717
[No Abstract] [Full Text] [Related]
2. Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.
Lai IC; Mo GH; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
Eur J Clin Pharmacol; 2011 Apr; 67(4):383-388. PubMed ID: 21181138
[TBL] [Abstract][Full Text] [Related]
3. Association of the Cholinergic Muscarinic M2 Receptor with Autonomic Nervous System Activity in Patients with Schizophrenia on High-Dose Antipsychotics.
Miyauchi M; Kishida I; Suda A; Shiraishi Y; Hattori S; Fujibayashi M; Taguri M; Ishii C; Ishii N; Moritani T; Hirayasu Y
Neuropsychobiology; 2016; 74(1):60-67. PubMed ID: 27923235
[TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms.
Srivastava V; Varma PG; Prasad S; Semwal P; Nimgaonkar VL; Lerer B; Deshpande SN; BK T
Pharmacogenet Genomics; 2006 Feb; 16(2):111-7. PubMed ID: 16424823
[TBL] [Abstract][Full Text] [Related]
5. Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.
Greenbaum L; Alkelai A; Rigbi A; Kohn Y; Lerer B
Mov Disord; 2010 Dec; 25(16):2809-17. PubMed ID: 20939080
[TBL] [Abstract][Full Text] [Related]
6. Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients.
Liu H; Wang C; Chen PH; Zhang BS; Zheng YL; Zhang CX; Meng HQ; Wang Y; Chen DC; Xiu MH; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):692-6. PubMed ID: 20346996
[TBL] [Abstract][Full Text] [Related]
7. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
Inada T; Koga M; Ishiguro H; Horiuchi Y; Syu A; Yoshio T; Takahashi N; Ozaki N; Arinami T
Pharmacogenet Genomics; 2008 Apr; 18(4):317-23. PubMed ID: 18334916
[TBL] [Abstract][Full Text] [Related]
8. Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia.
Lai IC; Liao DL; Bai YM; Lin CC; Yu SC; Chen JY; Wang YC
Neuropsychobiology; 2002; 46(4):173-5. PubMed ID: 12566932
[TBL] [Abstract][Full Text] [Related]
9. Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.
Liou YJ; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Mo GH; Lai IC
Am J Med Genet B Neuropsychiatr Genet; 2009 Mar; 150B(2):239-42. PubMed ID: 18548510
[TBL] [Abstract][Full Text] [Related]
10. Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia.
Loonen AJ; Wilffert B; Ivanova SA
Pharmacogenomics; 2019 Nov; 20(17):1199-1223. PubMed ID: 31686592
[TBL] [Abstract][Full Text] [Related]
11. Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia.
Liou YJ; Lai IC; Lin MW; Bai YM; Lin CC; Liao DL; Chen JY; Lin CY; Wang YC
Pharmacogenet Genomics; 2006 Mar; 16(3):151-7. PubMed ID: 16495774
[TBL] [Abstract][Full Text] [Related]
12. Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia.
Liou YJ; Wang YC; Chen JY; Bai YM; Lin CC; Liao DL; Chen TT; Chen ML; Mo GH; Lai IC
Psychiatry Res; 2007 Dec; 153(3):271-5. PubMed ID: 17669510
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia.
Chong SA; Tan EC; Tan CH; Mythily ; Chan YH
Am J Med Genet B Neuropsychiatr Genet; 2003 Jan; 116B(1):51-4. PubMed ID: 12497614
[TBL] [Abstract][Full Text] [Related]
14. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
[TBL] [Abstract][Full Text] [Related]
16. CHRM2 but not CHRM1 or CHRM3 polymorphisms are associated with asthma susceptibility in Mexican patients.
Jiménez-Morales S; Jiménez-Ruíz JL; Del Río-Navarro BE; Navarro-Olivos E; Escamilla-Guerrero G; Savan R; Dean M; Orozco L
Mol Biol Rep; 2014; 41(4):2109-17. PubMed ID: 24430298
[TBL] [Abstract][Full Text] [Related]
17. Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.
Fedorenko OY; Loonen AJ; Lang F; Toshchakova VA; Boyarko EG; Semke AV; Bokhan NA; Govorin NV; Aftanas LI; Ivanova SA
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548108
[TBL] [Abstract][Full Text] [Related]
18. Association between three functional polymorphisms of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia.
Hori H; Ohmori O; Shinkai T; Kojima H; Nakamura J
Am J Med Genet; 2001 Dec; 105(8):774-8. PubMed ID: 11803529
[TBL] [Abstract][Full Text] [Related]
19. Analysis of genetic variations in the human melatonin receptor (MTNR1A, MTNR1B) genes and antipsychotics-induced tardive dyskinesia in schizophrenia.
Lai IC; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
World J Biol Psychiatry; 2011 Mar; 12(2):143-8. PubMed ID: 20726823
[TBL] [Abstract][Full Text] [Related]
20. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphisms.
Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Lerer B; Nimgaonkar VL; Thelma BK
Schizophr Res; 2005 Jun; 75(1):21-6. PubMed ID: 15820320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
